HCC
NVEE

Hirtle Callaghan & Co’s NV5 Global NVEE Stock Holding History

Hirtle Callaghan & Co’s Portfolio NVEE Stock Details NVEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,608
Closed -$397K – 126
2022
Q2 		$397K Sell
13,608
-3,412
-20% -$102K 0.02% 95
2022
Q1 		$567K Buy
+17,020
New +$500K 0.03% 81

Other funds holding NVEE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hirtle Callaghan & Co's NVEE Position: Q3 2022 in Review

Hirtle Callaghan & Co sold out of NV5 Global (NVEE) in Q3 2022, closing a stake of 13,608 shares — an estimated $397K sold.

Hirtle Callaghan & Co first reported a position in NVEE in Q1 2022 and held it in 2 quarters. The position peaked at $567K in Q1 2022. 212 funds tracked by Wall St. Rank hold NVEE as of Q3 2022.

  • Hirtle Callaghan & Co reported no remaining NV5 Global position as of Q3 2022 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 13,608 NV5 Global shares in Q3 2022, an estimated $397K.
  • Hirtle Callaghan & Co first reported a position in NV5 Global in Q1 2022 and held it in 2 quarters.
  • Hirtle Callaghan & Co's NV5 Global position peaked at $567K in Q1 2022.
  • 212 funds tracked by Wall St. Rank held NV5 Global as of Q3 2022.

Based on Hirtle Callaghan & Co's 13F filing for Q3 2022, filed 14 Nov 2022.